Literature DB >> 2888970

Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus.

R H Notenboom, A Borczyk, M A Karmali, L M Duncan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888970     DOI: 10.1016/s0140-6736(87)91106-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157.

Authors:  H Kleanthous; N K Fry; H R Smith; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

2.  Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents.

Authors:  D Reymond; R P Johnson; M A Karmali; M Petric; M Winkler; S Johnson; K Rahn; S Renwick; J Wilson; R C Clarke; J Spika
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

3.  The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis.

Authors:  H Chart; O A Okubadejo; B Rowe
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

4.  The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome.

Authors:  H Chart; T Cheasty; D Cope; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

5.  Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.

Authors:  Armando Navarro; Carlos Eslava; Ulises Hernandez; Jose Luis Navarro-Henze; Magali Aviles; Guadalupe Garcia-de la Torre; Alejandro Cravioto
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

6.  The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.

Authors:  M Bitzan; K Ludwig; M Klemt; H König; J Büren; D E Müller-Wiefel
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

7.  Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

8.  Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7.

Authors:  R P Johnson; W C Cray; S T Johnson
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.